Journal of cardiac failure
Journal of cardiac failure
Audio Summaries
Every issue of Journal of cardiac failure moves the field forward, but reading every paper cover-to-cover isn't realistic. OSLR turns each article into a 3-minute audio summary so you can stay current while you commute, round, or work out.
Recent summaries
The latest articles summarized from Journal of cardiac failure.
A Novel Model to Predict Progression to Death After Withdrawal of Care in Potential Donation-After-Circulatory-Death Heart Donors
Jun 11, 2026
The authors aimed to develop a predictive model for determining the likelihood of progression to circulatory death in potential heart donors after the withdrawal of care. By analyzing various clinical factors and employing logistic regression and machine-learning techniques, they identified key predictors and achieved a high sensitivity and area under the curve (AUC) in both the development and external validation cohorts. This model could enhance decision-making in the context of donation after circulatory death (DCD).
Automated SCAI staging as a novel decision aid in cardiogenic shock management
Jun 11, 2026
The authors aimed to develop and assess the utility of an automated, electronic medical record-integrated staging tool for cardiogenic shock (CS) using the Society for Cardiovascular Angiography and Interventions (SCAI) criteria. Their findings indicate that the implementation of this automated staging significantly improved documentation of SCAI stages and enhanced surveillance practices, suggesting that early, serial automated staging may offer prognostic value in managing CS.
Impact of Mavacamten on Disease-Related Symptoms in Patients With Obstructive Hypertrophic Cardiomyopathy: HCMSQ Outcomes in EXPLORER-HCM
Jun 7, 2026
The authors aimed to evaluate the impact of mavacamten on disease-related symptoms in patients with obstructive hypertrophic cardiomyopathy (HCM) using the Hypertrophic Cardiomyopathy Symptom Questionnaire (HCMSQ). In a phase 3 trial, they found that mavacamten significantly improved symptoms such as shortness of breath and tiredness compared to placebo, with a notable proportion of patients experiencing meaningful symptom relief. Additionally, the study highlighted a correlation between HCMSQ scores and echocardiographic parameters, suggesting a link between symptom burden and cardiac function.